Salivary Secretor Status of Blood Group Antigens in Patients with Head and Neck Cancer
DOI:
https://doi.org/10.3889/oamjms.2019.101Keywords:
Head and neck cancer, Secretor status, Blood group antigensAbstract
BACKGROUND: Head and neck cancers include malignancies of the scalp and neck skin, nasal cavity, paranasal sinuses, oral cavity, salivary glands, pharynx and larynx. The term ABO secretor refers to people who secrete blood group antigens in their body fluids such as saliva, sweat, tears, semen, and serum. Non-secretors refer to those who do not secrete their blood group antigens in their body fluids. The lack of blood type antigens in body discharge increases the susceptibility to certain types of diseases and infection.
AIM: Our study aimed to investigate the relationship between the secretion of blood groups in the saliva of patients with head and neck cancers.
MATERIAL AND METHODS: This case-control study was performed on 110 people (57 patients with head and neck cancer who were referred to Imam Khomeini Hospital, Tehran and 53 cancer-free controls). Five ml of non-stimulated saliva were collected by the spitting method. By agglutination or lack of agglutination in the test tubes, we determined the patient’s secretor or non-secretor condition.
RESULTS: In terms of secretor status, 52.7% of all samples were secretors. In the case group, 19 out of 57 cases (33.3%) were secretors, and 38 were non-secretors (66.7%). In the control group, 39 out of 53 cases (73.6%) were secretors, and 14 cases were non-secretors (26.4%). There was a significant difference in the percentage of non-secretors between the two groups (p = 0.00).
CONCLUSION: People with non-secretor status may be more prone to develop head and neck cancer. The presence of these antigens in saliva may have a protective effect.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. https://doi.org/10.3322/caac.21254 PMid:25559415
Mirzaei M, Hosseini S-A, Ghoncheh M, Soheilipour F, Soltani S, Soheilipour F, et al. Epidemiology and trend of head and neck cancers in Iran. Glob J Health Sci. 2016; 8(1):189. https://doi.org/10.5539/gjhs.v8n1p189 PMid:26234980 PMCid:PMC4803954
Ragin C, Modugno F, Gollin S. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res. 2007; 86(2):104-14. https://doi.org/10.1177/154405910708600202 PMid:17251508
Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. The Lancet. 2008; 371(9625):1695-709. https://doi.org/10.1016/S0140-6736(08)60728-X
McMahon S, Chen AY. Head and neck cancer. Cancer Metastasis Rev. 2003; 22(1):21-4. https://doi.org/10.1023/A:1022203816340 PMid:12716033
Bakhtiari S, Mortazavi H, Mehdipour M, Jafarian N, Ranjbari N, Rahmani S.Frequency of Head and Neck Squamous Cell Carcinomas and Related Variables in SouthernIran (Ahvaz City): 10-Year Retrospective Study. Asian Pac J Cancer Prev. 2017; 18(2):375-379. PMid:28345334 PMCid:PMC5454730
Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao Y-T, et al. Tobacco and cancer: recent epidemiological evidence. J Nati Cancer Inst. 2004; 96(2):99-106. https://doi.org/10.1093/jnci/djh014
Boffetta P, Hashibe M. Alcohol and cancer. The lancet Oncol. 2006; 7(2):149-56. https://doi.org/10.1016/S1470-2045(06)70577-0
Hobbs C, Sterne J, Bailey M, Heyderman R, Birchall M, Thomas S. Human papillomavirus and head and neck cancer: a systematic review and metaâ€analysis. Clin Otolaryngol. 2006; 31(4):259-66. https://doi.org/10.1111/j.1749-4486.2006.01246.x PMid:16911640
Pavia M, Pileggi C, Nobile CG, Angelillo IF. Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. The Am J Clin Nutr. 2006; 83(5):1126-34. https://doi.org/10.1093/ajcn/83.5.1126 PMid:16685056
Suárez C, Rodrigo JP, Ferlito A, Cabanillas R, Shaha AR, Rinaldo A. Tumours of familial origin in the head and neck. Oral Oncol. 2006; 42(10):965-78. https://doi.org/10.1016/j.oraloncology.2006.03.002 PMid:16857415
Sturgis EM, Wei Q. Genetic susceptibility–molecular epidemiology of head and neck cancer. Curr Opin Oncol. 2002; 14(3):310-7. https://doi.org/10.1097/00001622-200205000-00010
D'Adamo P, Kelly GS. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Altern Med Rev. 2001; 6(4):390. PMid:11578255
Daniels, G. Human Blood Groups: Introduction, in Human Blood Groups, 3rd edition, Wiley-Blackwell, Oxford, UK, 2013. https://doi.org/10.1002/9781118493595.ch1
Javaud C, Dupuy F, Maftah A, Julien R, Petit JMThefucosyltransferase gene family: an amazing summary of the underlying mechanisms of gene evolution. Genetica. 2003; 118(2-3):157-70. https://doi.org/10.1023/A:1024101625214 PMid:12868606
Linden S, Mahdavi J, Semino-Mora C, Olsen C, Carlstedt I, Boren T, et al. Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS pathog. 2008; 4(1):e2. https://doi.org/10.1371/journal.ppat.0040002 PMid:18179282 PMCid:PMC2174967
Dayaprasad GK, Venkatesh D. Non-secretor status; a predisposing factor for vaginal candidiasis. Indian J Physiol Pharmacol. 2004; 48:225-9.
Thom S, Blackwell C, MacCallum C, Weir D, Brettle R, Kinane D, et al. Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol. 1989; 47(6-7):401-5. https://doi.org/10.1111/j.1574-6968.1989.tb02428.x PMid:2631880
Salih K, Jouda J, Al-Jaff S, El-Haboby B, Shaker E. Frequency of ABO blood groups and secretor status and their relation with dental decay in a section of students and employees of Al-Mustansiriyiah University in Iraq. World J Exp Biosci. 2015; 3:108-12.
Pradhan A, Chawla T, Samuel K, Pradhan M. The relationship between periodontal disease and blood groups and secretor status. J Periodontal Res. 1971; 6(4):294-300. https://doi.org/10.1111/j.1600-0765.1971.tb00620.x PMid:4272022
Lamey PJ, Darwazeh AM, Muirhead J, et al: Chronic hyperplastic candidosis and secretor status. J Oral Pathol Med. 1991; 20:64–67. https://doi.org/10.1111/j.1600-0714.1991.tb00891.x
Shin E-S, Chung S-C, Kim Y-K, Lee S-W, Kho H-S. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 96(1):48-53. https://doi.org/10.1016/S1079-2104(03)00160-4
Cerović R, Juretić M, Balen S, Belušić M, Caser L, Rogić M. Examining the presence of ABO (H) antigens of blood types in the saliva of patients with oral cancer. Coll Antropol. 2008; 32(2):509-12. PMid:18756902
Lamey P-J, Douglas P. Secretor status and oral cancer. Br J Oral Maxillofac Surg. 1994; 32(4):214-7. https://doi.org/10.1016/0266-4356(94)90205-4
Rai P, Acharya S, Hallikeri K. Assessment of ABO blood grouping and secretor status in the saliva of the patients with oral potentially malignant disorders. J Oral Maxillofac Pathol. 2015; 19(2):164. https://doi.org/10.4103/0973-029X.164527 PMid:26604491 PMCid:PMC4611923
Hallikeri K, Udupa R, Guttal K, Naikmasur V. Analysis of salivary secretor status in patients with oral submucous fibrosis: a caseâ€control study. J Investig Clin Dent. 2015; 6(4):261-6. https://doi.org/10.1111/jicd.12100 PMid:24850779
Jamil S, Tayyab M, Farooq M. Relationship of secretor status in patients with oral cancers. Annals of KEMU. 2016; 11(4). https://doi.org/10.21649/akemu.v11i4.1113
Karpati K, Braunitzer G, Toldi J, et al. Caries and ABO secretor status in a Hungarian population of children and adolescents: an exploratorystudy. Caries Res. 2014; 48:179–185. https://doi.org/10.1159/000356851 PMid:24480885
Campi C, Escovich L, Valdés V, GarcÃa Borrás S, Racca L, Racca A, et al. Secretor status and ABH antigens expression in patients with oral lesions. Med Oral Patol Oral Cir Bucal. 2007; 12(6):431-4.
Bakhtiari S, Toosi P, Dolati F, Bakhshi M. Evaluation of salivary secretor status of blood group antigens in patients with oral lichen planus. Med Princ Pract. 2016; 25(3):266-9. https://doi.org/10.1159/000442291 PMid:26554378 PMCid:PMC5588363
Garrett J, Whittaker J, Nicholson A, Ridway J, Bowman C. Blood-groups and secretor status in patients with salivary-gland tumours. The Lancet. 1971; 298(7735):1177-9. https://doi.org/10.1016/S0140-6736(71)90490-9
Vidas I, Temmerâ€Vuksan B. Examining the secretor status in the saliva of patients with oral preâ€cancerous lesions. J oral Rehabil. 1999; 26(2):177-82. https://doi.org/10.1046/j.1365-2842.1999.00314.x PMid:10080317
Shahidi-Dadras M, Golfeshan A, Abdollahimajd F. Evaluation of Secretory State in Patients with Oral Lichen Planus: A Case-Control Study. Arch Iran Med. 2016; 19(1):35-8. PMid:26702746
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Sedighe Bakhtiari, Soheila Mani Far, Zahra Alibakhshi, Mohammad Shirkhoda, Fahimeh Anbari

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0